Edgar Engleman - Net Worth and Insider Trading
Edgar Engleman Net Worth
The estimated net worth of Edgar Engleman is at least $14 Million dollars as of 2024-05-05. Edgar Engleman is the Director, 10% Owner of Soleno Therapeutics Inc and owns about 268,903 shares of Soleno Therapeutics Inc (SLNO) stock worth over $12 Million. Edgar Engleman is also the Director of Bolt Biotherapeutics Inc and owns about 2,073,005 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $2 Million. Details can be seen in Edgar Engleman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edgar Engleman has not made any transactions after 2023-11-30 and currently still holds the listed stock(s).
Transaction Summary of Edgar Engleman
Edgar Engleman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edgar Engleman owns 4 companies in total, including Soleno Therapeutics Inc (SLNO) , Eiger BioPharmaceuticals Inc (EIGRQ) , and Regenxbio Inc (RGNX) among others .
Click here to see the complete history of Edgar Engleman’s form 4 insider trades.
Insider Ownership Summary of Edgar Engleman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2017-12-15 | director & 10 percent owner |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2016-03-22 | director & 10 percent owner |
| RGNX | Regenxbio Inc | 2015-09-16 | director |
 | | 2023-11-30 | director |
Edgar Engleman Latest Holdings Summary
Edgar Engleman currently owns a total of 2 stocks. Among these stocks, Edgar Engleman owns 268,903 shares of Soleno Therapeutics Inc (SLNO) as of December 15, 2017, with a value of $12 Million and a weighting of 84.18%. Edgar Engleman also owns 2,073,005 shares of Bolt Biotherapeutics Inc (BOLT) as of November 30, 2023, with a value of $2 Million and a weighting of 15.82%.
Latest Holdings of Edgar Engleman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2017-12-15 | 268,903 | 45.12 | 12,132,903 |
| BOLT | Bolt Biotherapeutics Inc | 2023-11-30 | 2,073,005 | 1.10 | 2,280,306 |
Holding Weightings of Edgar Engleman
Edgar Engleman Form 4 Trading Tracker
According to the SEC Form 4 filings, Edgar Engleman has made a total of 0 transactions in Soleno Therapeutics Inc (SLNO) over the past 5 years. The most-recent trade in Soleno Therapeutics Inc is the acquisition of 72,365 shares on December 15, 2017, which cost Edgar Engleman around $2 Million.
According to the SEC Form 4 filings, Edgar Engleman has made a total of 5 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Bolt Biotherapeutics Inc is the sale of 148,884 shares on November 30, 2023, which brought Edgar Engleman around $129,529.
Insider Trading History of Edgar Engleman
- 1
Edgar Engleman Trading Performance
GuruFocus tracks the stock performance after each of Edgar Engleman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edgar Engleman is -9.78%. GuruFocus also compares Edgar Engleman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edgar Engleman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Edgar Engleman's insider trading performs compared to the benchmark.
Performance of Edgar Engleman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.73 | | | | | |
| Relative Return to S&P 500(%) | 9.12 | | | | | |
Edgar Engleman Ownership Network
Edgar Engleman Owned Company Details
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Edgar Engleman is the director & 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include 10 percent owner Vivo Opportunity Fund Holdings, L.p. , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Edgar Engleman made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net purchase of 1,210,087 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 196,136 shares made by Bhatnagar Anish , and a net sale of 52,057 shares made by Kristen Yen .
In summary, during the past 3 months, insiders sold 1,129,833 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,129,833 shares. During the past 18 months, 1,849,928 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 639,841 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
Edgar Engleman Mailing Address
Above is the net worth, insider trading, and ownership report for Edgar Engleman. You might contact Edgar Engleman via mailing address: 575 High Street, Ste 201, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
